ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266046; 2) Community: the network communities that were significantly associated with the response to NSC 266046; 3) Molecule: the relationships between components within communities and NSC 266046; 4) MDR: the compounds that were significantly associated with the NSC 266046.

NSC Compound Enrichment Correlation
NSC 685964 Null 0.0237269271456697 0.35566834
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.0237269271456697 0.35447554
NSC 693248 Null 0.0237269271456697 0.25443979
NSC 715407 Null 0.0237269271456697 0.38586741
NSC 718630 Null 0.0237269271456697 0.3820313
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0237269271456697 0.33635625
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0237269271456697 -0.037919027
NSC 726217 Combretastatin A4-analogue 0.0237269271456697 0.37012565
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0237269271456697 -0.10094838
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0237269271456697 0.45480166
Total:138  Current:88    [First] [Prev] [Next] [Last]